ARCHIVES

Satraplatin With Prednisone Reduces Risk Of Disease Progression By 33% In Study

This article is from The Cancer Letter archive.

Vol. 30 No. 3 | March 30, 2007

Download PDF Visit The Full Archive

Related Articles

FDA Approves Evista for Breast Cancer Risk Reduction.

September 14, 2007

NIH To Sponsor Animal Care, Human Protection Workshop

February 21, 1986

NCI Stands Firm On Assist “Downscaling” Despite 150 Letters From States, Volunteers

January 15, 1993

Protocols Approved By NCI

April 30, 2004

Coffey Presses NCI BSA chairman David Linvingston On support For Increase In NCI Budget

April 25, 1997

First Lady Recalls 1992 Meeting With NBCC, Credits Group For Progress In Breast Cancer

May 8, 1998